MedPath

Efficacy Evaluation of the Activity of a Cosmetic Product (Topical Use) on Hair Regrowth vs Placebo

Not Applicable
Completed
Conditions
Hypertrichosis
Registration Number
NCT03273504
Lead Sponsor
Derming SRL
Brief Summary

Aim of the study is to evaluate clinically and by non-invasive instrumental evaluations the activity on hair regrowth of a topical cosmetic product versus placebo (comparison within subjects)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
24
Inclusion Criteria
  • healthy volunteers
  • female sex
  • with hypertrichosis
  • agreeing not to perform epilation or scrub/peeling treatment on the test area (legs) during the week preceding the inclusion
  • good general state of health
Exclusion Criteria
  • pregnancy
  • lactation
  • subjects whose insufficient adhesion to the study protocol is foreseeable
  • sensitive skin
  • oral contraceptive therapy started less than 1 year
  • presence of varicose or capillary veins of surface
  • hormonal therapies able to influence hair growth.
  • presence of cutaneous disease on the tested area, as lesions, scars, malformations.
  • diabetes
  • endocrine disease
  • hepatic disorder
  • renal disorder
  • cardiac disorder
  • cancer.
  • farmacological topical treatment and surgery and/or medical treatment on the treated side performed in the last 3 months
  • systemic corticosteroids
  • aspirin or non-steroid anti-inflammatory drugs (FANS)
  • diuretic.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change from baseline of the hair densityBaseline (T0), 1 month (T1), 3 months (T3)

Hair density (hair number/mm2) is calculate by Image-Pro Plus software on the microscopic images captured with Dino-Lite (AnMo Electronics Corporation,Taiwan)

Change from baseline of hair regrowth speedBaseline (T0), 1 month (T1), 3 months (T3)

Hair regrowth speed (mm/die) is calculate by Image-Pro Plus software on the microscopic images captured with Dino-Lite (AnMo Electronics Corporation,Taiwan)

Change from baseline of the percentage of terminal hairBaseline (T0), 1 month (T1), 3 months (T3)

Percentage of terminal hair (terminal hair has a diameter \>0.04 mm) is calculate by Image-Pro Plus software on the microscopic images captured with Dino-Lite (AnMo Electronics Corporation,Taiwan)

Change from baseline of the percentage of vellus hairBaseline (T0), 1 month (T1), 3 months (T3)

Percentage of vellus hair (terminal hair has a diameter \<0.04 mm) is calculate by Image-Pro Plus software on the microscopic images captured with Dino-Lite (AnMo Electronics Corporation,Taiwan)

Secondary Outcome Measures
NameTimeMethod
Change from baseline of superficial skin hydrationBaseline (T0), 1 month (T1), 3 months (T3)

Skin electrical capacitance value is measured with Corneometer CM825 (Courage - Khazaka, Köln, Germany).

The measure of the skin capacitance properties is an indirect expression of its hydration level.

Trial Locations

Locations (1)

DERMING

🇮🇹

Milano, MI, Italy

DERMING
🇮🇹Milano, MI, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.